Ratings electroCore, Inc.

Equities

ECOR

US28531P2020

Real-time Estimate Cboe BZX Other stock markets 10:29:29 2024-05-20 am EDT			5-day change	1st Jan Change
7.01 ^USD	+0.14%		-3.45%	+17.61%

May. 08	Transcript : ElectroCore, Inc., Q1 2024 Earnings Call, May 08, 2024
May. 08	Earnings Flash (ECOR) ELECTROCORE Posts Q1 Revenue $5.4M, vs. Street Est of $4.8M	MT

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

The prospective high growth for the next fiscal years is among the main assets of the company
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Analyst opinion has improved significantly over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	ESG Refinitiv
ELECTROCORE, INC.	+17.61%	42.02M	D+
SHOCKWAVE MEDICAL, INC.	+73.22%	12.39B	B-
PENUMBRA, INC.	-20.19%	7.89B	C+
MASIMO CORPORATION	+7.62%	6.59B	C-
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+13.24%	5.43B	D+
APT MEDICAL INC.	+38.48%	4.96B	-
GETINGE AB	-17.16%	4.72B	B
ASAHI INTECC CO., LTD.	-18.76%	4.02B	B-
INARI MEDICAL, INC.	-29.40%	2.66B	C
NOVOCURE LIMITED	+56.40%	2.37B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes